India allows export of 10 lakh doses of vaccine to Bangladesh
Dhaka, October 8: The Government of India has given permission to the Serum Institute of India to export 10 lakh doses of Covishield vaccine each to Bangladesh, Nepal and Myanmar. Sources in the Indian Ministry of Health confirmed the information on Thursday.
Serum signed an agreement with Beximco to supply Covishield vaccine in Bangladesh. However, in March, April and May of this year, when the coronavirus infection became severe in India, the company stopped supplying the vaccine.
According to sources, Serum has also been allowed to supply about 3 crore doses of Covishield to AstraZeneca in the UK.
Prakash Kumar Singh, director (government and regulatory affairs) of Serum Institute of India, sought permission from Indian Health Minister Mansukh Mandaviya in August to export the vaccine, citing an agreement to supply the vaccine to AstraZeneca. Mandaviya said in an announcement on September 20 that India would resume surplus vaccine exports in October under the "Vaccine Friendship" program.
Mandaviya has said that the country would send 10 lakh doses of Bharat Biotech's Covaxin vaccine to Iran and in October, under the 'Vaccine Friendship' program, Serum would export 10 lakh doses of Covishield vaccine each to Myanmar, Nepal and Bangladesh.